pyrroles has been researched along with Ewing Sarcoma in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Coarfa, C; Kim, HR; Kurenbekova, L; Landesman, Y; Nakahata, K; Patel, TD; Qasim, SL; Rajapakshe, K; Shuck, R; Sierra, L; Unger, TJ; Wulff, J; Yustein, JT | 1 |
| Blay, JY; Cassier, P; Dufresne, A; Heudel, P; Pissaloux, D; Ray-Coquard, I; Wang, Q | 1 |
| Boichuk, S; Dunaev, P; Galembikova, A; Khaibullina, S; Khusnutdinov, R; Lombardi, V; Ramazanov, B; Zykova, S | 1 |
| Amin, HM; Benjamin, RS; Buford, AS; Daw, NC; Fokt, I; Lamhamedi-Cherradi, SE; Lazar, AJ; Ludwig, JA; Maywald, RL; Menegaz, BA; Mikos, AG; Naing, A; Priebe, W; Ramamoorthy, V; Ratan, R; Rohren, EM; Skora, S; Subbiah, V; Vishwamitra, D; Wang, J; Wang, Y | 1 |
| Caballero, G; de Alava, E; García-Sánchez, A; Herrero, D; Mackintosh, C; Madoz-Gúrpide, J; Martins, AS; Ordoñez, JL; Osuna, D; Otero, AP; Poremba, C; Sevillano, V | 1 |
| Astolfi, A; Belfiore, A; Carè, A; Conte, A; Garofalo, C; Grilli, A; Manara, MC; Mancarella, C; Marino, MT; Picci, P; Scotlandi, K; Sigismund, S | 1 |
| Benini, S; Croci, S; García-Echeverría, C; Hofmann, F; Lollini, PL; Lukas, S; Manara, MC; Nicoletti, G; Perdichizzi, S; Picci, P; Scotlandi, K; Serra, M; Zambelli, D | 1 |
| Campos, M; de Alava, E; Hernández, T; Mackintosh, C; Martín, DH; Martins, AS; Ordóñez, JL | 1 |
| García-Echeverría, C; Hofmann, F; Landuzzi, L; Lollini, PL; Manara, MC; Nanni, C; Nanni, P; Nicoletti, G; Picci, P; Scotlandi, K; Zambelli, D | 1 |
1 review(s) available for pyrroles and Ewing Sarcoma
| Article | Year |
|---|---|
[Molecular biology of sarcoma and therapeutic choices].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Benzamides; Bone Neoplasms; Crizotinib; Denosumab; Dermatofibrosarcoma; Gastrointestinal Stromal Tumors; Gene Amplification; Gene Deletion; Giant Cell Tumor of Bone; Humans; Imatinib Mesylate; Indoles; Molecular Targeted Therapy; Phenylurea Compounds; Piperazines; Point Mutation; Prognosis; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Sarcoma; Sarcoma, Ewing; Sunitinib; Synovitis, Pigmented Villonodular; Translocation, Genetic | 2015 |
8 other study(ies) available for pyrroles and Ewing Sarcoma
| Article | Year |
|---|---|
p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma.
Topics: Acrylamides; Aminopyridines; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Interferon-alpha; Interferon-gamma; p21-Activated Kinases; Pyrazoles; Pyrroles; Sarcoma, Ewing; Signal Transduction; Xenograft Model Antitumor Assays | 2021 |
Ethyl-2-amino-pyrrole-3-carboxylates are novel potent anticancer agents that affect tubulin polymerization, induce G2/M cell-cycle arrest, and effectively inhibit soft tissue cancer cell growth in vitro.
Topics: Antineoplastic Agents; Bone Neoplasms; Carboxylic Acids; Cell Death; Cell Growth Processes; Cell Line, Tumor; G2 Phase Cell Cycle Checkpoints; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Leiomyosarcoma; M Phase Cell Cycle Checkpoints; Osteosarcoma; Pyrroles; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Tubulin; Tubulin Modulators | 2016 |
IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma.
Topics: Adenosine Triphosphatases; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cation Transport Proteins; Cell Line, Tumor; Copper-Transporting ATPases; Drug Resistance, Neoplasm; Drug Synergism; Humans; Imidazoles; Insulin Receptor Substrate Proteins; Male; Mice; Mice, SCID; Neoplasm Transplantation; Nucleocytoplasmic Transport Proteins; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Protein Array Analysis; Pyrazines; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Receptors, Somatomedin; Sarcoma, Ewing; Sirolimus; STAT3 Transcription Factor; TOR Serine-Threonine Kinases; Up-Regulation | 2016 |
A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo study.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Cell Proliferation; Drug Resistance, Neoplasm; Electrophoresis, Gel, Two-Dimensional; HSP90 Heat-Shock Proteins; Humans; Imatinib Mesylate; In Vitro Techniques; Piperazines; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Sarcoma, Ewing | 2008 |
Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Immunoglobulins, Intravenous; Insulin-Like Growth Factor II; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Receptor, Insulin; Sarcoma, Ewing; Signal Transduction | 2012 |
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Osteosarcoma; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Signal Transduction; Vincristine | 2005 |
Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drug Screening Assays, Antitumor; G1 Phase; Humans; Imatinib Mesylate; Phosphorylation; Piperazines; Protein Kinases; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Sarcoma, Ewing; Structure-Activity Relationship; TOR Serine-Threonine Kinases; Vincristine | 2006 |
Preclinical in vivo study of new insulin-like growth factor-I receptor--specific inhibitor in Ewing's sarcoma.
Topics: Animals; Female; Humans; Mice; Mice, Nude; Neoplasm Metastasis; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Sarcoma, Ewing; Xenograft Model Antitumor Assays | 2007 |